Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
---|
08/28/2003 | WO2003070908A2 Novel spinosyn-producing polyketide synthases |
08/28/2003 | WO2003070907A2 Novel fungal lipase |
08/28/2003 | WO2003070904A2 Human rnase iii and compositions and uses thereof |
08/28/2003 | WO2003070901A2 Heat stable mutants of starch biosynthesis enzymes |
08/28/2003 | WO2003070767A1 Tissue specific expression |
08/28/2003 | WO2003070746A2 Purification and characterization of a prothrombin activator from the bristled of lonomia obliqua |
08/28/2003 | WO2003070740A1 RIBOZYMES WITH BROAD tRNA AMINOACYLATION ACTIVITY |
08/28/2003 | WO2003070204A2 Lipase inhibiting composition |
08/28/2003 | WO2003070164A2 Attenuated mycobacterium tuberculosis vaccines |
08/28/2003 | WO2003069980A2 Precise breeding |
08/28/2003 | WO2003060136A3 D-galacturonate reductase of fragaria ananassa and its use in methods for increasing production of vitamin c in plants |
08/28/2003 | WO2003053158A3 Malleable protein matrix and uses thereof |
08/28/2003 | WO2003046163A3 Multifunctional caffeic acid o-methyltransferase |
08/28/2003 | WO2003038079A3 A mammalian mucinase, its recombinant production, and its use in therapy or prophylaxis against diseases in which mucus is involved or infectious diseases |
08/28/2003 | WO2003033713A3 Production of oil with higher erucic acid content |
08/28/2003 | WO2003020912A3 Novel clark protein and nucleic acid molecules and uses therefor |
08/28/2003 | WO2003014321A3 Compositions and methods for modulation of darpp-32 phosphorylation |
08/28/2003 | WO2003014148A3 Human fatty acid-coa ligase |
08/28/2003 | WO2003012114A3 Methods of rna and protein synthesis |
08/28/2003 | WO2003012088A3 Nucleic acid molecules encoding a glucosinolate sulfatase |
08/28/2003 | WO2003010318A3 Desulfoglucosinolate sulfotransferases, sequences coding the same and uses thereof for modulating glucosinolate biosynthesis in plants |
08/28/2003 | WO2003005957A3 Mutants of clostridium septicum alpha toxin and vaccines, antibodies, sera, and methods of treatment therewith |
08/28/2003 | WO2003004674A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
08/28/2003 | WO2003004619A3 Nucleic acids encoding glucosinolate biosynthesis enzymes and methods of their use |
08/28/2003 | WO2003002105A3 Use of tyrosine kinase inhibitors for treating bone loss |
08/28/2003 | WO2003000858A3 Pharmacological targeting of bacterial dna ligase for treatment and prevention of bacterial infections |
08/28/2003 | WO2002093173A3 Screening method using pim1-kinase or pim3-kinase |
08/28/2003 | WO2002088362A3 Regulation of human prostaglandin-f synthase 1-like protein |
08/28/2003 | WO2002088345A3 Murine dnasex, medicament containing the same and non-human mammal comprising modified dnasex gene |
08/28/2003 | WO2002086137A3 Process for the production of l-amino acids by fermentation using coryneform bacteria |
08/28/2003 | WO2002086112A3 Nucleic acid molecules encoding starch degrading enzymes |
08/28/2003 | WO2002083720A3 Intermediates and enzymes of the non-mevalonate isoprenoid pathway |
08/28/2003 | WO2002081687A3 Yeast genes that affect viral replication |
08/28/2003 | WO2002062369A3 Uroguanylin and cyclooxygenase-2 inhibitor combinations for inhibition of intestinal cancer |
08/28/2003 | WO2002061092A3 Regulation of human lysyl oxidase |
08/28/2003 | WO2002034940A3 Methods for screening compounds that modulate lipid metabolism |
08/28/2003 | WO2002034922A3 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
08/28/2003 | WO2002033088A3 Human carboxypeptidase, scramblase, and protocadherin family members and uses thereof |
08/28/2003 | WO2002022527A3 Design and production of mutant 2,5-diketo-d-gluconic acid reductase enzymes with altered cofactor dependency |
08/28/2003 | WO2002012470A3 A member of the lysyl oxidase gene family |
08/28/2003 | WO2002008433A3 Acyl coenzyme a thioesterases |
08/28/2003 | WO2002008399A3 Human kinases |
08/28/2003 | WO2002008274A3 56939, a human acyl-coa thioesterase family member and uses thereof |
08/28/2003 | WO2002002780A3 Human serine-threonine kinase |
08/28/2003 | WO2001079489A3 39228, a human alcohol dehydrogenase and uses therefor |
08/28/2003 | US20030163856 Genetic engineering of gene expression, disenabling ATP production in the mitochondria of plants; antifertility treatment |
08/28/2003 | US20030163851 Plant having improved tolerance to various environmental stresses, method of constructing the same and polyamine metabolism-relating enzyme gene |
08/28/2003 | US20030163847 Reversible male sterility in transgenic plants by expression of cytokinin oxidase |
08/28/2003 | US20030163845 Elongase genes and uses thereof |
08/28/2003 | US20030163844 Genes for microsomal delta-12 fatty acid desaturases and related enzymes from plants |
08/28/2003 | US20030163842 Novel plant receptor-like kinases |
08/28/2003 | US20030163838 Adjusting concentration of cellulose synthase in plants; genetic engineering |
08/28/2003 | US20030163837 Genetic engineering; transgenic plants |
08/28/2003 | US20030163836 In situ detection of enzyme inhibitors |
08/28/2003 | US20030163835 Hydrogen peroxide lyase regulatory region |
08/28/2003 | US20030163834 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of Erk-5 |
08/28/2003 | US20030162942 Binding to ligand; adjustment of pH; elution |
08/28/2003 | US20030162786 Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric G protein |
08/28/2003 | US20030162743 Matrix metalloproteinase and tumor necrosis factor inhibitors |
08/28/2003 | US20030162691 Novel antimicrobial therapies |
08/28/2003 | US20030162300 Galactomannan-oligosaccharides and methods for the production and use thereof |
08/28/2003 | US20030162294 Genes involved in tolerance to environmental stress |
08/28/2003 | US20030162280 Enzyme isolated from a Bifidobacterium |
08/28/2003 | US20030162279 22438, 23553, 25278, and 26212 novel human sulfatases |
08/28/2003 | US20030162278 Use for development of human therapeutic proteins; amino acid sequences, allelic variants, isolated polypeptide, antibody and nucleic acids, transgenic non-human animal, culturing the host cell, genetic engineering |
08/28/2003 | US20030162277 Calcium/calmodulin-dependent kinase |
08/28/2003 | US20030162275 Expressed in baculovirus system in insect cells; xenobiotic metabolizing enzymes |
08/28/2003 | US20030162273 Modulation of sulfate permease for photosynthetic hydrogen production |
08/28/2003 | US20030162271 Homologous recombination; transposition; comprises xylose isomerase, xylulokinase, transketolase, and transaldolase; for production of ethanol |
08/28/2003 | US20030162262 A recombinant host cell, which in its untransformed state does not produce narbonolide, that consists of a recombinant DNA expression vector that encodes a narbonolide (polyketide synthase) PKS and produces narbonolide |
08/28/2003 | US20030162253 Recombinant plasmid psp1, microorganisms transformed therewith, and method for producing an alkaline protease vapk |
08/28/2003 | US20030162250 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
08/28/2003 | US20030162218 High-throughput screening of expressed DNA libraries in filamentous fungi |
08/28/2003 | US20030162206 Central nervous system disorders; antiinflammatory agnets; antidiabetic agents |
08/28/2003 | US20030162201 Cloned DNA polymerases from Thermotoga and mutants thereof |
08/28/2003 | US20030162191 Enzyme inhibitors; microbiocides, antiinflamamtory agents, viricides, antitumor agents; gene therapy |
08/28/2003 | US20030162173 Nucleic acid modifying enzymes |
08/28/2003 | US20030162171 Test kit for tuberculosis diagnosis by determining alanine dehydrogenase |
08/28/2003 | US20030162169 Screening enzyme inhibitors |
08/28/2003 | US20030162168 Surrogate cell-based system and method for assaying the activity of hepatitis C virus NS3 protease |
08/28/2003 | US20030161831 Identification of polynucleotides encoding proteins having DGAT and MGAT activity, as well as the proteins encoded comprising a nucleotide sequence that has at least 50% nucleotide sequence identified; antilipemic agents |
08/28/2003 | US20030161830 Novel human histone deacetylases |
08/28/2003 | US20030161823 Therapeutic and cosmetic uses of heparanases |
08/28/2003 | US20030161822 Killing grampositive bacteria |
08/28/2003 | US20030159706 Enzyme composition for bleaching human keratinous fibres and bleaching method |
08/28/2003 | CA2775650A1 Decreased reducing sugars in plants for the reduction of acrylamide production in heated foods |
08/28/2003 | CA2486388A1 Novel fungal lipase |
08/28/2003 | CA2486381A1 Lipase inhibiting composition |
08/28/2003 | CA2475540A1 Heat stable mutants of starch biosynthesis enzymes |
08/28/2003 | CA2474802A1 Process for producing levodione |
08/28/2003 | CA2474780A1 Enone reductase |
08/28/2003 | CA2471410A1 Purifying process of soluble proteins of the l. obliqua bristles through prothrombin activation; process for a partial determination of the amino acids sequence of the prothrombinactivator; process for determining the prothrombin activation of fraction ii, n-terminal and internal fragments sequences |
08/28/2003 | CA2373903A1 Increasing plant seed production |
08/27/2003 | EP1338650A1 Cellulase preparation containing nonionic surfactant and method of treating fiber |
08/27/2003 | EP1338646A2 Use of xyloglucan endotransglycosylase (xet) |
08/27/2003 | EP1338282A1 Uridine derivatives as Matrix Metalloproteinase (MMP) and Tumor Necrosis Factor (TNF) inhibitors for the treatment of cancer |
08/27/2003 | EP1337655A2 Retroviral vectors containing internal ribosomal entry sites |
08/27/2003 | EP1337653A2 Controlled environment agriculture bioreactor for heterologous protein production |
08/27/2003 | EP1337652A1 Manipulation of the phenolic acid content and digestibility of plant cell walls by targeted expression of genes encoding cell wall degrading enzymes |
08/27/2003 | EP1337650A1 Transgenic animals for analysing cyp3a4 cytochrome p450 gene regulation |